Victrex/£VCT
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Victrex
Victrex PLC, founded in 1993 and headquartered in Thornton Cleveleys, UK, is a company that specializes in the manufacturing of high-performance polymeric solutions. It operates in the Specialty Chemicals sector within the materials industry, offering products made primarily from PEEK and PAEK-based materials used in a wide range of sectors including automotive, aerospace, energy, electronics, and medical. Its operations focus on both the development and production of these advanced polymer solutions, catering to both industrial and medical applications across various global markets.
Ticker
£VCT
Sector
Primary listing
LSE
Industry
Chemicals
Headquarters
Employees
1,131
Website
Victrex Metrics
BasicAdvanced
£614M
20.70
£0.34
-
£0.60
8.44%
Price and volume
Market cap
£614M
52-week high
£11.60
52-week low
£6.68
Average daily volume
261K
Dividend rate
£0.60
Financial strength
Current ratio
3.809
Quick ratio
1.522
Long term debt to equity
12.54
Total debt to equity
15.237
Dividend payout ratio (TTM)
174.41%
Interest coverage (TTM)
23.62%
Profitability
EBITDA (TTM)
71.5
Gross margin (TTM)
42.64%
Net profit margin (TTM)
9.98%
Operating margin (TTM)
16.67%
Effective tax rate (TTM)
27.88%
Revenue per employee (TTM)
£260,000
Management effectiveness
Return on assets (TTM)
5.21%
Return on equity (TTM)
6.01%
Valuation
Price to earnings (TTM)
20.7
Price to revenue (TTM)
2.066
Price to book
1.42
Price to tangible book (TTM)
1.48
Price to free cash flow (TTM)
9.444
Free cash flow yield (TTM)
10.59%
Free cash flow per share (TTM)
74.76%
Dividend yield (TTM)
8.44%
Growth
Revenue change (TTM)
4.75%
Earnings per share change (TTM)
-1.32%
3-year revenue growth (CAGR)
-1.93%
10-year revenue growth (CAGR)
1.25%
3-year earnings per share growth (CAGR)
-24.90%
10-year earnings per share growth (CAGR)
-10.10%
10-year dividend per share growth (CAGR)
2.73%
What the Analysts think about Victrex
Analyst ratings (Buy, Hold, Sell) for Victrex stock.
Bulls say / Bears say
Jefferies upgraded Victrex to 'Buy', citing a compelling recovery opportunity in FY25 driven by demand resurgence in most segments of Sustainable Solutions, excluding automotive, and potential favorable raw material cost developments. (Investing.com)
Deutsche Bank upgraded Victrex to 'Buy', highlighting the company's strong cash generation, completion of major capacity expansion, and attractive valuation metrics, including a 6.6% free cash flow yield and a 6.2% dividend yield for FY25. (Proactive Investors)
Victrex reported a 20% increase in sales volumes to 898 tonnes in Q1 FY25, with revenue growing by 9% to £66.6 million, indicating potential for continued growth despite challenges in the medical division. (Proactive Investors)
Victrex's CEO Jakob Sigurdsson stepped down after almost eight years, coinciding with a 3% decline in Q3 revenue to £71.5 million and weaker sales volumes, raising concerns about leadership stability and financial performance. (Proactive Investors)
JPMorgan downgraded Victrex's stock rating from 'Overweight' to 'Neutral' and reduced the price target to £10.50, citing concerns over weaker macroeconomic data from the U.S., ongoing trade tariff uncertainties, and a significant decline in return on invested capital. (Investing.com)
Victrex reported a 17% decline in pretax profit to £23.2 million in H1 FY25, with average selling prices dropping to £72.3/kg, leading to a gross margin contraction of 390 basis points to 44.1%, indicating profitability challenges. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.
Victrex Financial Performance
Revenues and expenses
Victrex Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Victrex stock?
Victrex (VCT) has a market cap of £614M as of July 25, 2025.
What is the P/E ratio for Victrex stock?
The price to earnings (P/E) ratio for Victrex (VCT) stock is 20.7 as of July 25, 2025.
Does Victrex stock pay dividends?
Yes, the Victrex (VCT) stock pays dividends to shareholders. As of July 25, 2025, the dividend rate is £0.5956 and the yield is 8.44%. Victrex has a payout ratio of 174.41% on a trailing twelve-month basis.
When is the next Victrex dividend payment date?
The next Victrex (VCT) dividend payment date is unconfirmed.
What is the beta indicator for Victrex?
Victrex (VCT) does not currently have a Beta indicator.